rhErythropoietin-b as a tissue protective agent in kidney transplantation: a pilot randomized controlled trial

BACKGROUND: Extended criteria donor (ECD) and donation after circulatory death (DCD) kidneys are at increased risk of delayed graft function (DGF). Experimental evidence suggests that erythropoietin (EPO) attenuates renal damage in acute kidney injury. This study piloted the administration of high d...

Descripción completa

Detalles Bibliográficos
Autores principales: Coupes, Beatrice, de Freitas, Declan G, Roberts, Stephen A, Read, Ian, Riad, Hany, Brenchley, Paul EC, Picton, Michael L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330593/
https://www.ncbi.nlm.nih.gov/pubmed/25643790
http://dx.doi.org/10.1186/s13104-014-0964-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330593/
https://www.ncbi.nlm.nih.gov/pubmed/25643790
http://dx.doi.org/10.1186/s13104-014-0964-0

Ejemplares similares